NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for ATHE

Based on 1 analyst offering 12 month price targets for Alterity Therapeutics Ltd

Min Forecast
$12.00+189.16%
Avg Forecast
$12.00+189.16%
Max Forecast
$12.00+189.16%

Should I buy or sell ATHE stock?

Based on 1 analyst offering ratings for Alterity Therapeutics Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATHE stock forecasts and price targets.

ATHE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-30

1 of 1

ATHE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHE$4.15$12.00+189.16%Strong Buy
NRSN$1.91N/AN/A
MURA$2.58$11.00+326.36%Strong Buy
PRLD$0.79$4.50+466.75%Buy
ATNM$1.44$4.00+177.78%Buy

Alterity Therapeutics Stock Forecast FAQ

Is Alterity Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ATHE) stock is to Strong Buy ATHE stock.

Out of 1 analyst, 1 (100%) are recommending ATHE as a Strong Buy, 0 (0%) are recommending ATHE as a Buy, 0 (0%) are recommending ATHE as a Hold, 0 (0%) are recommending ATHE as a Sell, and 0 (0%) are recommending ATHE as a Strong Sell.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What is ATHE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ATHE price target, the average ATHE price target is $12.00, with the highest ATHE stock price forecast at $12.00 and the lowest ATHE stock price forecast at $12.00.

The Wall Street analyst predicted that Alterity Therapeutics's share price could reach $12.00 by Jan 30, 2026. The average Alterity Therapeutics stock price prediction forecasts a potential upside of 189.16% from the current ATHE share price of $4.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.